1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-24-126766 |
2024-11-14 08:30:21 |
10-Q
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-24-236039 |
2024-10-10 17:31:01 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-24-234814 |
2024-10-09 08:40:04 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-24-097022 |
2024-08-14 16:14:00 |
10-Q
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-24-158318 |
2024-06-10 16:05:30 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-24-142317 |
2024-05-20 08:55:02 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-24-060579 |
2024-05-15 17:04:56 |
10-Q
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-24-084902 |
2024-04-02 17:12:09 |
8-K/A
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-24-037160 |
2024-03-27 16:05:36 |
10-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-24-025941 |
2024-02-07 07:59:02 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-24-021850 |
2024-02-01 16:09:53 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-24-008593 |
2024-01-16 16:31:03 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-23-063713 |
2023-11-14 16:15:27 |
10-Q
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-23-256998 |
2023-10-16 17:24:04 |
10-K/A
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-23-238295 |
2023-09-20 11:23:58 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-23-042389 |
2023-08-14 16:07:30 |
10-Q
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-23-188223 |
2023-07-17 17:29:28 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-23-178328 |
2023-06-29 12:15:30 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-23-176725 |
2023-06-28 07:08:54 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-23-021974 |
2023-05-15 08:01:27 |
10-Q
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-23-011133 |
2023-03-31 07:10:42 |
10-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-23-076674 |
2023-03-22 16:04:53 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-23-069219 |
2023-03-13 17:26:56 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-23-061524 |
2023-03-06 16:55:55 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-23-016224 |
2023-01-26 16:02:58 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-23-014850 |
2023-01-25 09:00:03 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-23-014226 |
2023-01-24 16:27:05 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-22-287698 |
2022-11-17 16:30:02 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-22-025011 |
2022-11-14 17:10:41 |
10-Q
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-22-279041 |
2022-11-07 16:01:31 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-22-246370 |
2022-09-16 16:09:05 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-22-236658 |
2022-09-01 17:30:03 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-22-221288 |
2022-08-15 17:12:13 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-22-017140 |
2022-08-12 16:33:16 |
10-Q
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-22-013406 |
2022-07-28 17:55:59 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-22-012322 |
2022-06-29 16:01:08 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-22-152247 |
2022-05-16 21:49:03 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-22-010085 |
2022-05-16 16:18:36 |
10-Q
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-22-113033 |
2022-04-21 16:19:18 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-22-005203 |
2022-03-31 16:12:47 |
10-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-22-083462 |
2022-03-24 09:17:10 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-22-080588 |
2022-03-21 16:30:54 |
8-K/A
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-22-069346 |
2022-03-08 16:38:02 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001104659-22-005932 |
2022-01-20 16:10:47 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0000950170-21-004620 |
2021-11-15 16:33:25 |
10-Q
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001104659-21-127621 |
2021-10-19 17:03:04 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001104659-21-113776 |
2021-09-08 15:46:15 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-21-249270 |
2021-08-17 17:02:56 |
8-K
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001564590-21-044637 |
2021-08-16 16:16:02 |
10-Q
|
1750149 |
IKT |
Inhibikase Therapeutics, Inc. |
0001193125-21-202362 |
2021-06-28 20:25:58 |
8-K
|